» Articles » PMID: 32577216

Digital Transformation of Health and Care to Sustain Planetary Health: The MASK Proof-of-concept for Airway Diseases-POLLAR Symposium Under the Auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance Against Chronic...

Abstract

In December 2019, a conference entitled "Europe That Protects: Safeguarding Our Planet, Safeguarding Our Health" was held in Helsinki. It was co-organized by the Finnish Institute for Health and Welfare, the Finnish Environment Institute and the European Commission, under the auspices of Finland's Presidency of the EU. As a side event, a symposium organized as the final POLLAR (Impact of air POLLution on Asthma and Rhinitis) meeting explored the digital transformation of health and care to sustain planetary health in airway diseases. The Finnish Allergy Programme collaborates with MASK (Mobile Airways Sentinel NetworK) and can be considered as a proof-of-concept to impact Planetary Health. The Good Practice of DG Santé (The Directorate-General for Health and Food Safety) on digitally-enabled, patient-centred care pathways is in line with the objectives of the Finnish Allergy Programme. The ARIACARE-Digital network has been deployed in 25 countries. It represents an example of the digital cross-border exchange of real-world data and experience with the aim to improve patient care. The integration of information technology tools for climate, weather, air pollution and aerobiology in mobile Health applications will enable the development of an alert system. Citizens will thus be informed about personal environmental threats, which may also be linked to indicators of Planetary Health and sustainability. The digital transformation of the public health policy was also proposed, following the experience of the Agency for Health Quality and Assessment of Catalonia (AQuAS).

Citing Articles

From biodiversity to nature deficiency in human health and disease.

Haahtela T, Bousquet J, Anto J Porto Biomed J. 2024; 9(1):245.

PMID: 38344457 PMC: 10857682. DOI: 10.1097/j.pbj.0000000000000245.


Clinical endpoints in allergen immunotherapy: State of the art 2022.

van Wijk R, Klimek L, Pfaar O Allergol Select. 2023; 7:39-46.

PMID: 36925995 PMC: 10012882. DOI: 10.5414/ALX02334E.


Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.

Bousquet J, Anto J, Sousa-Pinto B, Czarlewski W, Bedbrook A, Haahtela T Clin Transl Allergy. 2023; 13(1):e12215.

PMID: 36705508 PMC: 9823305. DOI: 10.1002/clt2.12215.


eHealth Platforms to Promote Autonomous Life and Active Aging: A Scoping Review.

Bernardo J, Apostolo J, Loureiro R, Santana E, Yaylagul N, Dantas C Int J Environ Res Public Health. 2022; 19(23).

PMID: 36498018 PMC: 9738367. DOI: 10.3390/ijerph192315940.


Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.

Sousa-Pinto B, Anto A, Berger M, Dramburg S, Pfaar O, Klimek L Clin Transl Allergy. 2022; 12(11):e12208.

PMID: 36434742 PMC: 9673175. DOI: 10.1002/clt2.12208.


References
1.
Haahtela T, Valovirta E, Bousquet J, Makela M . The Finnish Allergy Programme 2008-2018 works. Eur Respir J. 2017; 49(6). DOI: 10.1183/13993003.00470-2017. View

2.
Bousquet J, Bedbrook A, Czarlewski W, Onorato G, Arnavielhe S, Laune D . Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019; 9:16. PMC: 6413444. DOI: 10.1186/s13601-019-0252-0. View

3.
Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E . MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018; 8:45. PMC: 6201545. DOI: 10.1186/s13601-018-0227-6. View

4.
Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I . Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2). J Thorac Dis. 2019; 11(9):4072-4084. PMC: 6790426. DOI: 10.21037/jtd.2019.09.38. View

5.
Bachert C, Bousquet J, Hellings P . Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018; 8:25. PMC: 6016145. DOI: 10.1186/s13601-018-0210-2. View